Up-regulation of p-ERK in the MTC post-treatment group suggested that activated AKT and MTC may activate ERK, resulting in increased cell survival and axonal regeneration after MTC treatment (Figure 7). This evidence concerns the gene AKT1 and medullary thyroid gland carcinoma.